Preliminary Clinical Experience of<i>trans</i>-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (<i>anti</i>-(18)F-FACBC) PET/CT Imaging in Prostate Cancer Patients

According to our preliminary clinical experience, [(18)F]-FACBC-PET may play a role in in vivo restaging of an active prostate cancer, especially in patients with a short S-PSA doubling time.